RIGEL PHARMACEUTICALS, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2022
Total Assets: $134.3M
Liabilities Breakdown FY2022
Total Liabilities: $147.9M
Asset Breakdown
Total Assets: $134.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $24.5M | 18.2% |
| Accounts Receivable | $40.3M | 30.0% |
| Inventory | $9.1M | 6.8% |
| Property, Plant & Equipment | $857.0K | 0.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $14.9M | 11.1% |
| Other Assets | $44.6M | 33.2% |
Liabilities Breakdown
Total Liabilities: $147.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $22.5M | 15.2% |
| Long-Term Debt | $40.0M | 27.0% |
| Other Liabilities | $85.4M | 57.7% |